Timothy C. Dec

Timothy C. Dec, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Supernus Pharmaceuticals, Inc. and CapForce Inc. The record holds 17 filings, for trades running from 17 May 2021 to 12 August 2026.

No open-market purchase appears, only 1 sale worth €451k. Outside the open market, there are 9 share grants and 7 option exercises.

On 14 August 2026 came the latest disclosure, an option exercise in Supernus Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.